ClinicalTrials.gov
public full text
Public Domain
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
This is a Phase 1b, open-label, study to assess the effects of AK002, given as monthly intravenous infusion for 6 doses at up to 3 mg/kg.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.#868942
- A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis#882536
- Viral Conjunctivitis Treatment Study#894007
- Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy#826230
- Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis#1087654
Record · ID 914545
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive